
SoFi Technologies (NASDAQ:SOFI) Reports Strong Q2 Earnings, Driving Stock Surge
SoFi Technologies' stock is up 7% ahead of its Q2 earnings report, while Apellis Pharmaceuticals' stock rose 13% after positive results from its SYFOVRE drug.
All articles tagged with #stock gainers

SoFi Technologies' stock is up 7% ahead of its Q2 earnings report, while Apellis Pharmaceuticals' stock rose 13% after positive results from its SYFOVRE drug.